Optimizing tissue sampling for the diagnosis, subtyping and molecular analysis of lung cancer

Frontiers in Oncology

Volumn 4, Issue SEP, 2014, Pages

  Ofiara, L M ^a   Navasakulpong, A ^a   Beaudoin, S ^a   Gonzalez, A V ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bronchoscopy; Diagnosis; Diagnostic yield; EGFR; Lung cancer; Molecular biomarkers; Thoracoscopy; Transthoracic needle aspiration; Ultrasound bronchoscopy (EBUS)

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P63;

BLEEDING; BRONCHOSCOPIC NAVIGATION SYSTEM; BRONCHOSCOPY; BRONCHUS TUMOR; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOLOGY; DIAGNOSTIC VALUE; ENDOBRONCHIAL ULTRASONOGRAPHY; FLUOROSCOPY; HISTOLOGY; HOARSENESS; HUMAN; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; INFECTION; LUNG CANCER; MEDIASTINOSCOPY; MOLECULAR TYPING; NON SMALL CELL LUNG CANCER; PLEURA FLUID; PLEURODESIS; PNEUMOTHORAX; SHORT SURVEY; THORACOSCOPY; TRANSBRONCHIAL ASPIRATION; TRANSBRONCHIAL BIOPSY; TRANSTHORACIC BIOPSY; ULTRASOUND GUIDED BRONCHOSCOPY;

EID: 84907006525     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00253     Document Type: Short Survey

References (66)

1. Advisory Committee on Cancer Statistics. (2013) Canadian Cancer Statistics. Toronto, ON: Canadian Cancer Society.
2. Pfister DG, Johnson DH, Azzoli CG et al. American Society of Clinical Oncology. Treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22:330-53.
3. Kerr KM. Personalized medicine for lung cancer: new challenges for pathology. Histopathology 2012; 60:531-46.
4. Scagliotti GV, Hanna N, Fossella F, et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies. Oncologist 2009; 14:253-63.
5. Rosell R, Carcereny E, Gervais R et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation positive non-small cell lung cancer (EURTAC) A multicentre, open-label randomized phase 3 trial. Lancet Oncol. 2012; 13; 239-46.
6. Zhou C, Wu YL, Chen G, et al. Erlotinib versus chemotherapy as first line treatment for patients with advanced EGFR mutation positive non-small cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open label, randomized phase 3 trial. Lancet Oncol 2011: 12; 435-42.
7. Wu YL, Zhou C, Hu C-P, et al. LUX- Lung 6: A randomized, open label phase 3 study of Afatanib versus gemcitabine-cisplatin as first line treatment for Asian patients with EGFR mutation positive advanced adenocarcinoma. J Clin Oncol 2013 (suppl) 490s, abstr 8016.
8. Kwak EL, Bang YJ, Camidge DR et al. Anaplastic lymphoma kinase inhibition in non-small cell lung cancer. N Engl J Med 2010; 363:1693-703.
9. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ 2011; 342:d2110
10. Simpson FG, Arnold AG, Purvis A, et al. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax 1986:41:311-17.
11. British Thoracic Society Bronchoscopy Guidelines Committee, a subcommittee of the Standards of Care Committee of the British Thoracic Society. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001; 56(suppl 1):i1-21.
12. Mazzone P, Jain P, Arroliga AC, Matthay RA. Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med 2002; 23:137-58.
13. Gellert AR, Rudd RM, Sinha G, et al. Fiberoptic bronchoscopy: effect of multiple biopsies on diagnostic yield in bronchial carcinoma. Thorax 1982; 37:684-7.
14. Bodh A, Kaushal V, Kashap S, Gutali A. A cytohistological correlation in diagnosis of lung tumours by using fiberoptic bronchoscopy: Study of 200 cases. Indian J Pathol Microbiol 2013; 56:84-8.
15. Chen WT, Chao TY, Wu CP, et al. Comparison of the diagnostic yield of bronchial brushing cytology before and after endobronchial biopsy of flexible fiberoptic bronchoscopy-A prospective study. J Med Sci. 1997; 18:165-70.
16. Coghlin CL, Smith LJ, Bakar S, et al: Quantitative analysis of tumor in bronchial biopsy specimens. J Thorac Oncol 5:448-52, 2010
17. Schmid-Bindert G et al. EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods. PLoS One. 2013 Oct 29;8(10):e77948
18. Hetzel J et al. Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J 2012; 39: 685-690
19. Schumann C et al. Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg 2010; 140:417-21.
20. Baaklini WA, Reinoso MA, Gorin AB, et al: Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules. Chest 117:1049-54, 2000
21. Rivera MP, Mehta AC: Initial diagnosis of lung cancer. ACCP evidence based clinical practice guidelines. Chest 132 (suppl 3):131S-148S, 2007
22. Laroche C, Fairbairn I, Moss H et al. Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer. Thorax 2000; 55:359-363.
23. Allegrini S, Antona J, Mezzapelle R, et al. Epidermal growth factor receptor gene analysis with a highly sensitive molecular assay in routine cytologic specimens of lung adenocarcinoma. Am J Clin Pathol. 2012;138:377-381
24. Kurimoto N, Nakamura H, Miyazawa T: Overview of Endobronchial Ultrasonography in Chest Medicine. Journal of Medical Ultrasound 17:31-43, 2009
25. Eberhardt R, Anantham D, Ernst A, et al. Multimodality bronchoscopic diagnosis of peripheral lung lesions. A randomized controlled trial. Am J Respir Crit Care Med 2007; 176:37-41.
26. Asahina H, Yamazaki K, Onodera Y, et al. Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigation. Chest 2005; 128:1761-1765
27. Asano F, Matsuno Y, Tsuzuku A, et al. Diagnosis of peripheral pulmonary lesions using a bronchoscope insertion guidance system combined with endobronchial ultrasonography with a guide sheath. Lung Cancer 2008; 60:366-373
28. Tzu-Hsiu T, Ching-Yao Y, et al. Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy. Lung Cancer 2013; 82(3):420-25
29. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006;61:795-8.
30. Annema JT, van Meerbeeck JP, Rintoul RC, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010;304:2245-2252
31. Almeida FA, Uzbeck M, Jimenez C, et al. Flexible bronchoscopy and endobronchial ultrasound needle aspiration (EBUS-TBNA) vs other invasive modalities in the initial diagnosis and staging of suspected or confirmed lung cancer. Chest 2010; 138:423A. Abstract
32. Herth FJ: Nonsurgical staging of the mediastinum: EBUS and EUS. Semin Respir Crit Care Med 32:62-8, 2011
33. Nakajima T, Yasufuku K, Nakajima M, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in nonoperable patients pursuing radiotherapy as a primary treatment. J Thorac Oncol 2010; 5:606-611
34. Lee HS, Lee GK, Lee HS, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest 2008; 134:386-74.
35. Nakajima T, Yasafuku K, Suzuki M et al. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasound-guided transbronchial needle aspiration. Chest 132(2):597-602, 2007
36. Schuurbiers OC, Looijen-Salamon MG, Ligtenberg MLJ et al. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol 5(10):1664-1667, 2010.
37. Garcia-Olive I. Monso E. Andreo F et al. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. Eur Respir J 35(2):391-395, 2010.
38. Yamus L, Akulian J, Gilbert C et al. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc 2013; Dec 10(6):636-43.
39. Navasakulpong A, Jung S, Gonzalez AV. Implementation and feasibility of EGFR testing using endobronchial ultrasound guided needle aspirates (EBUS-TBNA) in patients with non-small cell lung cancer. Abstract accepted ATS May 2014 presentation
40. Schmid-Bindert G et al. EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods. PLoS One. 2013 Oct 29;8(10):e77948
41. Herth FJ: Nonsurgical staging of the mediastinum: EBUS and EUS. Semin Respir Crit Care Med 32:62-8, 2011
42. Toloza EM, Harpole L, Detterbeck F, et al: Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123:157S-166S, 2003
43. Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thor Surg 82(4),:1185-9, 2006
44. Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasoundguided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011; 142:1393-1400 e1391
45. Schreiber G, McCrory DC: Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 123:115S-128S, 2003
46. Klein JS, Salomon G, Stewart EA: Transthoracic needle biopsy with a coaxially placed 20-gauge automated cutting needle: results in 122 patients. Radiology 198:715-20, 1996
47. ERS/ATS statement on interventional pulmonology.Eur Respir J 2002;19: 365-373
48. Laurent F, Latrabe V, Vergier B, et al. Percutaneous CT-guided biopsy of the lung: comparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc Interven Radiol 2000; 23: 266-72.
49. Levine MS, Weiss JM, Harrell JH, et al. Transthoracic needle aspiration biopsy following negative fiberoptic bronchoscopy in solitary pulmonary nodules. Chest 1988; 93: 1152-5.
50. Pirker R, Herth FJ, Kerr KM, et al. Consensus for EGFR testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 2010; 5(10): 1706-13
51. Zhuang YP, Wang HY, Shi MQ, et al. Use of CT-guided fine needle aspiration biopsy in epidermal growth factor receptor mutation analysis in patients with advanced lung cancer. Acta Radiol 2011; 52:1083-1087
52. Fassina A, Gazziero A, Zardo D, et al. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. Journal of Clinical Pathology 2009; 62:1096-1102
53. Da Cuhna Santos G, Lai SW, Saieg MA, et al. Cyto-histologic agreement in pathologic subtyping of non-small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype. Lung Cancer 2012; 77(3): 501-6.
54. Rivera MP, Mehta AC: Initial diagnosis of lung cancer. ACCP evidence based clinical practice guidelines. Chest 132 (suppl 3):131S-148S, 2007
55. Sears D, Hajdu SI: The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 31:85-97, 1987
56. Boutin C, Viallat JR, Cargnino P, et al: Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 124:588-92, 1981
57. Billah S, Stewart J, Staerkel G, et al: EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol 119:111-7, 2011
58. Rahman NM, Ali NJ, Brown G, et al. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii54-60
59. Roberts ME, Neville N, Berrisford RG et al. Management of a malignant pleural effusion. British Thoracic Society guidelines. Thorax 65(2) ii32-40, 2010.
60. Dan Liu, Yachao Lu, Zhenli Hu, et al. Malignant pleural effusion supernatants are substitutes for metastatic pleural tumour tissues in EGFR mutation test in patients with advanced lung adenocarcinoma. PLoS One. 2014; 9(2): e89946
61. Menzies R, Charbonneau M: Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 114:271-6, 1991
62. Boutin C, Viallat JR, Cargnino P, et al: Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 124:588-92, 1981
63. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of Lung cancer in small biopsies and cytology. Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2013; 137: 668-84.
64. Thunnissen E, Kerr KM, Herth FJF, et al. The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 2012; 76:1-18.
65. Lindeman NI, Cagle PT, Beasley MB et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists (CAP), International Association for the Study of Lung Cancer(IASLC), Association of Molecular Pathologists (AMP). Arch Pathol Lab Med 2013;137(6): 828-60
66. Travis WD, Brambilla E, Noguchi M et al. International Association of the Study of Lung Cancer/American Thoracic Society/European respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6(2):244-285, 2011